MI Arrowhead Publishers and Conferences
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sitte, H. H.
Right arrow Articles by Javitch, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sitte, H. H.
Right arrow Articles by Javitch, J. A.
Molecular Interventions 4:38-47 (2004)
© 2004 American Society of Pharmacology and Experimental Therapeutics


Review

Sodium-Dependent Neurotransmitter TRANSPORTERS: OLIGOMERIZATION as a Determinant of Transporter Function and Trafficking

Harald H. Sitte1, Hesso Farhan1 and Jonathan A. Javitch2

1 Institute of Pharmacology, Medical University Vienna A-1090 Vienna, Austria and
2 Center for Molecular Recognition and Departments of Psychiatry and Pharmacology, College of Physicians and Surgeons, Columbia University, New York, NY 10032


Constitutive oligomer formation appears to be the rule for the neurotransmitter:sodium symporter (NSS) family of proteins. The propensity to form oligomers is a prerequisite for NSS proteins to pass the rigid mechanisms of quality control in the endoplasmic reticulum. Moreover, recent findings suggest that correct trafficking to the plasma membrane appears to rely on the interaction of NSS homo-oligomers with components of the COPII-vesicle machinery. The transporters present at the plasma membrane are most likely organized in a tetrameric arrangement, as a dimer of dimers. In this review, we will address ongoing efforts to unravel the underlying mechanisms of oligomer formation at the molecular and cellular levels, and we will discuss oligomerization in terms of transporter function.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L. Kao, P. Sassani, R. Azimov, A. Pushkin, N. Abuladze, J. Peti-Peterdi, W. Liu, D. Newman, and I. Kurtz
Oligomeric Structure and Minimal Functional Unit of the Electrogenic Sodium Bicarbonate Cotransporter NBCe1-A
J. Biol. Chem., September 26, 2008; 283(39): 26782 - 26794.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Ruggiero, Y. Liu, S. Vidensky, S. Maier, E. Jung, H. Farhan, M. B. Robinson, H. H. Sitte, and J. D. Rothstein
The Endoplasmic Reticulum Exit of Glutamate Transporter Is Regulated by the Inducible Mammalian Yip6b/GTRAP3-18 Protein
J. Biol. Chem., March 7, 2008; 283(10): 6175 - 6183.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
E. Bossi, A. Soragna, A. Miszner, S. Giovannardi, V. Frangione, and A. Peres
Oligomeric structure of the neutral amino acid transporters KAAT1 and CAATCH1
Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1379 - C1387.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. M. Korkhov, M. Holy, M. Freissmuth, and H. H. Sitte
The Conserved Glutamate (Glu136) in Transmembrane Domain 2 of the Serotonin Transporter Is Required for the Conformational Switch in the Transport Cycle
J. Biol. Chem., May 12, 2006; 281(19): 13439 - 13448.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. K. Hahn, M. S. Mazei-Robison, and R. D. Blakely
Single Nucleotide Polymorphisms in the Human Norepinephrine Transporter Gene Affect Expression, Trafficking, Antidepressant Interaction, and Protein Kinase C Regulation
Mol. Pharmacol., August 1, 2005; 68(2): 457 - 466.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. W. Schwartz, G. Novarino, D. W. Piston, and L. J. DeFelice
Substrate Binding Stoichiometry and Kinetics of the Norepinephrine Transporter
J. Biol. Chem., May 13, 2005; 280(19): 19177 - 19184.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.